ALX Oncology Holdings Inc.
ALXO
M
|
$14.58
2.46%
41K
|
Commercial Services
(0.0% 1d) (21.4% 1m) (160.1% 1y) (0.0% 2d) (0.0% 3d) (-8.8% 7d) (-39.78% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 729,000,000
http://alxoncology.com
Sec Filling | Patents | 58 employees
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA.
cancer myeloid leukemia leukemia msa treatment
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $7.74 55.11% 2.7M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
SPCE 4 | $0.943 25.42% 30M
|
Electronic Technology
Last 48 Hours Insiders Buying
TPL P 3 | $585.25 -0.1% 4.7K
|
Miscellaneous
|
15:00
ETST P 79000 | $0.065 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $22.0 2.33% 29K
|
Consumer Durables
|
00:00
YORW P 29 | $35.6 0.51% 11K
|
Utilities
|
19:01
VUZI P 14500 | $1.34 -0.74% 84K
|
Electronic Technology
|
17:00
BANF P 256 | $92.43 1.26% 5.7K
|
Finance
|
15:30
RMCF | $3.57 170
|
Consumer Non-Durables
|
20:10